- Home
- JYNT vs RGC Comparison
JYNT vs RGC Comparison
Compare JYNT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- RGC
- Stock Information
- Founded
- JYNT 2010
- RGC 2014
- Country
- JYNT United States
- RGC Hong Kong
- Employees
- JYNT N/A
- RGC N/A
- Industry
- JYNT Multi-Sector Companies
- RGC Medicinal Chemicals and Botanical Products
- Sector
- JYNT Miscellaneous
- RGC Health Care
- Exchange
- JYNT Nasdaq
- RGC Nasdaq
- Market Cap
- JYNT 163.0M
- RGC 171.1M
- IPO Year
- JYNT 2014
- RGC 2021
- Fundamental
- Price
- JYNT $11.70
- RGC $5.32
- Analyst Decision
- JYNT Strong Buy
- RGC
- Analyst Count
- JYNT 2
- RGC 0
- Target Price
- JYNT $18.00
- RGC N/A
- AVG Volume (30 Days)
- JYNT 46.8K
- RGC 37.2K
- Earning Date
- JYNT 11-07-2024
- RGC 10-25-2024
- Dividend Yield
- JYNT N/A
- RGC N/A
- EPS Growth
- JYNT N/A
- RGC N/A
- EPS
- JYNT N/A
- RGC N/A
- Revenue
- JYNT $120,071,078.00
- RGC N/A
- Revenue This Year
- JYNT $0.70
- RGC N/A
- Revenue Next Year
- JYNT N/A
- RGC N/A
- P/E Ratio
- JYNT N/A
- RGC N/A
- Revenue Growth
- JYNT 7.46
- RGC N/A
- 52 Week Low
- JYNT $7.31
- RGC $3.03
- 52 Week High
- JYNT $17.82
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- JYNT 51.57
- RGC 38.69
- Support Level
- JYNT $10.80
- RGC $5.52
- Resistance Level
- JYNT $12.02
- RGC $6.57
- Average True Range (ATR)
- JYNT 0.40
- RGC 0.76
- MACD
- JYNT 0.14
- RGC -0.27
- Stochastic Oscillator
- JYNT 81.10
- RGC 0.00
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.